. 2020 Mar 18;24(1):3–15. doi: 10.4103/ijoem.IJOEM_50_20

Table 3.

Chronological evolution of pneumococcal vaccine recommendations[65,66]

Advocacy group/body	Recommendation/s
Global Initiative for Chronic Obstructive Lung Disease (GOLD, 2019)[65]	PCV13 and PPSV23 recommended for all patients ≥65 years of age. PPSV23 also recommended for younger COPD patients with significant comorbid conditions, including chronic heart or lung disease.
Advisory Committee on Immunization Practices (ACIP, 2019)[66]	ACIP recommends administration of PCV13 based on shared clinical decision-making for adults aged ≥65 years (who do not have an immunocompromising condition [e.g., CSF leak, or cochlear implant] and who have not previously received PCV13). If the decision is made to administer PCV13, it should be given at least 1 year before PPSV23. PCV13 and PPSV23 should not be co-administered. ACIP continues to recommend PCV13 in series with PPSV23 for adults aged ≥19 years with an immunocompromising condition, CSF leak, or cochlear implant.

Advocacy group/body

Recommendation/s

Global Initiative for Chronic Obstructive Lung Disease (GOLD, 2019)[65]

PCV13 and PPSV23 recommended for all patients ≥65 years of age.
PPSV23 also recommended for younger COPD patients with significant comorbid conditions, including chronic heart or lung disease.

Advisory Committee on Immunization Practices (ACIP, 2019)[66]

ACIP recommends administration of PCV13 based on shared clinical decision-making for adults aged ≥65 years (who do not have an immunocompromising condition [e.g., CSF leak, or cochlear implant] and who have not previously received PCV13).
If the decision is made to administer PCV13, it should be given at least 1 year before PPSV23. PCV13 and PPSV23 should not be co-administered.
ACIP continues to recommend PCV13 in series with PPSV23 for adults aged ≥19 years with an immunocompromising condition, CSF leak, or cochlear implant.

COPD: chronic obstructive lung disease; PPSV23: 23-valent pneumococcal polysaccharide vaccine; PCV13: 13-valent pneumococcal conjugate vaccine; CSF: cerebrospinal fluid